Dan Cohen - Neurologist, Inventor & Serial Entrepreneur | The Hidden Link Between Sleep and Success

➡️ Start Here: https://stan.store/scottdclary

➡️ Like The Podcast? Leave A Rating: https://ratethispodcast.com/successstory

➡️ Join 321,000 people who read my free weekly newsletter: https://newsletter.scottdclary.com

➡️ About The Guest

Dr. Daniel Cohen is a neurologist and serial entrepreneur. He co-founded Soltec Health to study the healing effect of magnetic waveforms on sleep and neurodegenerative conditions. Previously, Dr. Cohen co-founded and managed CNS, Inc. until it was acquired by GlaxoSmithKline in 2006 for $566M. CNS, a developer and marketer of hi-tech medical products (brainwave monitors and sleep disorders diagnostic equipment) was best known for its consumer products, the Breathe Right® nasal strip and the FiberChoice™ chewable fiber supplement.

He holds numerous patents related to EEG and sleep analysis algorithms and devices and additional utility patents related to synchronized sound, vibration and electro-magnetic fields. Dr. Cohen has a BS from Penn State University and received his MD from Temple Medical School with high distinction. His training is in Neurology at the University of Minnesota and is a Diplomat of the American Board of Psychiatry and Neurology.

➡️ Show Links

https://www.linkedin.com/in/dan-cohen-md-55b33287/  

https://soltechealth.com/ 

➡️ Podcast Sponsors

Hubspot - https://hubspot.com/  

Stan - https://join.stan.store/scottdclary

Business Made Simple Podcast - https://businessmadesimple.com 

NetSuite — https://netsuite.com/scottclary/ 

Indeed - https://indeed.com/clary

Range Rover Sport - https://www.landroverusa.com/ 

CIBC Innovation Banking Podcast - https://www.innovationbanking.cibc.com/podcasts/ 

LinkedIn Jobs - https://linkedin.com/excellence

➡️ Talking Points

00:00 - Intro

02:43 - Doctor Turned Entrepreneur

07:57 - Dan’s First Business Fail

23:01 - Spotting a Winning Product

24:44 - Sponsor: Business Made Simple Podcast

25:14 - Taking a Product to Market

33:45 - Selling to a Public Company